Wellinks closed a $10 million Series B to accelerate growth and expand patient access to its predictive cardiopulmonary care model.
- Amount
- $10M
- Stage
- Series B
- Announced
- 4 August 2026
- Investors
- UMass Memorial Health
- Use of funds
- to accelerate growth and expand patient access to its predictive care model
- Checked
- Announced by the company